Assignee
ANNJI PHARM CO LTD
TW·7 granted patents·2 pending applications·7 citations·filing 2013–2022
Top patents by PatentIndex Score
9 records- 0177US9155739B2Histone deacetylases (HDACs) inhibitorsANNJI PHARM CO LTD·Filed 2015·Granted Oct 13, 2015·3 cites·20 claims
- 0271US8946282B2Indolin-2-one derivatives as protein kinase inhibitorsANNJI PHARM CO LTD·Filed 2013·Granted Feb 3, 2015·3 cites·18 claims
- 0366US9387209B2Histone deacetylases (HDACs) inhibitorsANNJI PHARM CO LTD·Filed 2013·Granted Jul 12, 2016·1 cites·15 claims
- 0456US11413256B2Method for treating a neurodegenerative disorderANNJI PHARM CO LTD·Filed 2019·Granted Aug 16, 2022·0 cites·9 claims
- 0553US8969361B2Cyclopropanecarboxylate esters of purine analoguesANNJI PHARM CO LTD·Filed 2013·Granted Mar 3, 2015·0 cites·18 claims
- 0646US2025339385A1Topical formulation of dimethylcurcuminANNJI PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0740US9302992B2Multifunctional quinoline derivatives as anti-neurodegenerative agentsANNJI PHARM CO LTD·Filed 2013·Granted Apr 5, 2016·0 cites·19 claims
- 0840US2023212129A1Quinazoline derivatives useful as selective hdac6 inhibitorsANNJI PHARM CO LTD·Filed 2021·Application pending·0 cites
- 0936US11535598B2Histone deacetylases (HDACs) inhibitorsANNJI PHARM CO LTD·Filed 2018·Granted Dec 27, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when ANNJI PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →